首页> 美国卫生研究院文献>Journal of Veterinary Science >Evaluation of modified vaccinia virus Ankara expressing VP2 protein of infectious bursal disease virus as an immunogen in chickens
【2h】

Evaluation of modified vaccinia virus Ankara expressing VP2 protein of infectious bursal disease virus as an immunogen in chickens

机译:表达鸡传染性法氏囊病病毒VP2蛋白的改良牛痘病毒安卡拉作为免疫原的评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

A recombinant modified vaccinia Ankara (MVA) virus expressing mature viral protein 2 (VP2) of the infectious bursal disease virus (IBDV) was constructed to develop MVA-based vaccines for poultry. We demonstrated that this recombinant virus was able to induce a specific immune response by observing the production of anti-IBDV-seroneutralizing antibodies in specific pathogen-free chickens. Besides, as the epitopes of VP2 responsible to induce IBDV-neutralizing antibodies are discontinuous, our results suggest that VP2 protein expressed from MVA-VP2 maintained the correct conformational structure. To our knowledge, this is the first report on the usefulness of MVA-based vectors for developing recombinant vaccines for poultry.
机译:表达传染性法氏囊病病毒(IBDV)的成熟病毒蛋白2(VP2)的重组修饰牛痘安卡拉(MVA)病毒被构建用于开发基于MVA的家禽疫苗。我们证明了这种重组病毒能够通过观察无特定病原体的鸡中抗IBDV血清中和抗体的产生来诱导特定的免疫反应。此外,由于负责诱导IBDV中和抗体的VP2抗原决定簇是不连续的,我们的结果表明,由MVA-VP2表达的VP2蛋白保持正确的构象结构。就我们所知,这是关于基于MVA的载体在开发家禽重组疫苗方面的有用性的首次报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号